SecBot SecBot
PRESS-RELEASE ·Filed Mar 5, 2026

NYXH

Nyxoah
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Traders should prepare for the March 19 earnings release and listen to the call for potential updates on U.S. commercialization, revenue trends, and cash position, which could impact the stock given the company's small market cap.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
NYXH ▼ -19.25% at T+60d
NEUTRAL call -19.25% · α vs SPY -32.03% · entry $3.74 → $3.02
Entry = T+0 close
Mar 5, 2026
via day close
T+1d
-6.68%
call -6.68% · α -7.53%
$3.49
settled 8mo ago
T+5d
-16.04%
call -16.04% · α -14.51%
$3.14
settled 8mo ago
T+20d
-6.42%
call -6.42% · α -4.37%
$3.50
settled 7mo ago
T+60d
-19.25%
call -19.25% · α -32.03%
$3.02
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Nyxoah announced it will release its fourth quarter and full year 2025 financial results on March 19, 2026, followed by a conference call. The press release contains no actual financial data, only logistical details for the upcoming earnings announcement.

Key Facts

  • Nyxoah will release Q4 and FY 2025 financial results on March 19, 2026.
  • Management will host a conference call the same day at 4:30pm ET.
  • No financial results, guidance, or operational metrics were disclosed in this release.
  • The Genio system received FDA approval in August 2025 for moderate to severe OSA patients.

Financial Impact

No financial impact from this release — results not yet disclosed.

Risk Factors

  • No financial data provided in this release limits immediate trading utility.
  • Forward-looking statements carry high uncertainty, especially for a company in early-stage commercialization.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3250651
13 reports for NYXH
Performance horizon
70% Hit rate @ T+1 7 of 10 directional calls Went positive at some point 9 of 10 best @ T+5▲ +12.98%Oct 19, 2026
Filters
Rows
Reports for NYXH — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
6-K
BEARISH ★ 6/10
$0.8950 $0.8220▲ +8.16%▲ +6.98%$0.9001 (−0.57%)
Oct 19, 2026
8d ago
Press Release
BEARISH ★ 6/10
$0.9540 $0.9400▲ +1.47%▲ +1.80%$0.9001 (+5.65%)
Sep 22, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$1.33 $1.27▼ −4.51%▼ −4.43%$0.9001 (−32.32%)
Jun 23, 2026
17w ago
6-K
BEARISH ★ 6/10
$1.62 $1.63▼ −0.62%▼ −0.47%$0.9001 (+44.44%)
Jun 11, 2026
19w ago
6-K
BEARISH ★ 7/10
$1.39 $1.55▼ −11.51%▼ −9.75%$0.9001 (+35.24%)
Jun 8, 2026
20w ago
6-K
BEARISH ★ 7/10
$1.34 $1.31▲ +2.24%▲ +0.66%$0.9001 (+32.83%)
Jun 8, 2026
20w ago
424B5
BEARISH ★ 7/10
$1.39 $1.34▲ +3.60%▲ +3.30%$0.9001 (+35.24%)
Jun 5, 2026
20w ago
Press Release
BEARISH ★ 7/10
$1.45 $1.39▲ +4.14%▲ +4.36%$0.9001 (+37.92%)
Jun 4, 2026
20w ago
424B5
BEARISH ★ 7/10
$1.45 $1.39▲ +4.14%▲ +4.36%$0.9001 (+37.92%)
May 20, 2026
22w ago
Press Release
BULLISH ★ 5/10
$2.87 $2.87· 0.00%▼ −0.45%$0.9001 (−68.64%)
Showing 10 of 13

US Market Status

Market Open — Closes in 1h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026